Guideline-directed medical therapy and dose titration are essential to improving outcomes in heart failure with reduced or mildly reduced ejection fraction.According to the CDC, 6.7 million U.S.
Panelists discuss how guideline-directed medical therapy has evolved to include 4-pillar treatment for heart failure with reduced ejection fraction (angiotensin-converting enzyme ...
The approach could help clinicians who are “burdened with information overload” manage their patients, one expert says.
Please provide your email address to receive an email when new articles are posted on . Digitoxin reduced risk for death or worsening heart failure vs. placebo in patients with heart failure with ...
Vericiguat is a candidate for inclusion in guideline-directed medical therapy for heart failure with reduced ejection fraction, based on a meta-analysis showing an all-cause death reduction on top of ...
Panelists discuss how β-blockers remain foundational therapy for heart failure with reduced ejection fraction (using evidence-based agents like carvedilol, metoprolol succinate, or bisoprolol) with ...
Innovaccer Inc., a leading healthcare AI company, today announced results from the VITAL-HF (Virtual Care to Improve Heart Failure Outcomes) randomized controlled trial, presented today at the Heart ...
Heart failure with preserved ejection function is a lethal form of heart failure, with few effective treatments. A team has now identified an enzyme, alpha-kinase 2 (ALPK2), that is specifically ...
(Cardiome Pharma, Vancouver, BC) reduced serum concentrations of uric acid but failed to improve clinical status over six months in a randomized trial that included a broad population of patients with ...
Doctors say that identifying the right patients will be critical to the future of the field. Only time will tell, according ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results